Skip to content

Self magazine has compounding story that gets into details

Self has a long, well-balanced article on not just the current state of GLP-1 compounding, but a broad overview of compounding in general. That includes something we rarely see in the mainstream media: discussion of how APIs are sourced. It even goes into the difference between 503As and 503Bs. (Yes, our fingerprints are on the piece, but not overly so. We were just glad to help the reporter get the full story.)

Read "Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs."